Champions Oncology (CSBR)
(Delayed Data from NSDQ)
$4.56 USD
+0.02 (0.44%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $4.31 -0.25 (-5.48%) 6:14 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Champions Oncology, Inc. [CSBR]
Reports for Purchase
Showing records 1 - 20 ( 38 total )
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for CSBR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Reasons to Sit Down with These Healthcare/Biotech Management
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E